Urigen Pharmaceuticals, Inc.
Urigen Pharmaceuticals, Inc. (UGRP.OB) is a publicly traded company in the Unknown sector. Across all available filings, 3 corporate insiders have executed 57 transactions totaling $76.6K, demonstrating a bullish sentiment with $76.6K in net insider flow. The most recent transaction on Oct 5, 2009 involved a purchase of 10,000 shares valued at $700.
UGRP.OB Insider Activity Summary
Who Is Buying UGRP.OB Stock?
No significant insider buying has been recorded for UGRP.OB in the recent period.
Who Is Selling UGRP.OB Stock?
No significant insider selling has been recorded for UGRP.OB in the recent period.
Is Urigen Pharmaceuticals, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for UGRP.OB is bullish with an Insider Alignment Score of 100/100 and a net flow of $76.6K. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
UGRP.OB Frequently Asked Questions
Understanding UGRP.OB Insider Activity
Insider trading at Urigen Pharmaceuticals, Inc. (UGRP.OB) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 3 insiders are actively trading UGRP.OB stock, having executed 57 transactions in the past 90 days. The most active insider is Martin E. Shmagin (Executive), who has made 26 transactions totaling $40.7K.
Related Tools
Track Urigen Pharmaceuticals, Inc. Insider Activity
Get notified when executives and directors at UGRP.OB file new Form 4 transactions